Protective Efficacy of Mg-Supplementation Against NRTI-induced Cardiac Toxicity
Protective Efficacy of Mg-Supplementation Against NRTI-induced Cardiac Toxicity
批准号:
7229233
负责人:
Ivan Tong Mak
金额:
$22.95万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-30 至 2008-09-29
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Zidovudine (AZT) cardiotoxicity in HIV patients has been well documented, but the potential beneficial effect of magnesium (Mg)-supplementation has never be explored. AZT toxicity is linked to increased oxidative stress which may be mediated by abnormal iron status. Since other clinically used nucleoside reverse transcriptase inhibitor (NRTI) drugs are structurally similar to AZT, their potential interaction with endogenous iron may represent a common mechanism of oxidative toxicity. Our in vitro studies suggest that AZT synergizes with iron in causing endothelial cytotoxicity and that supra levels of extracellular magnesium are cytoprotective. This proposal will explore whether dietary supplementation of either Mg oxide (inorganic) or Mg gluconate (an organic salt) will attenuate chronic NRTI-induced systemic inflammation and cardiac injury n vivo, and if the protective mechanism(s) associated with the Mg supplements can be revealed using NRTI- treated in vitro models. The specific aims are: (1) Determine the differential protective effects of upplemental inorganic and organic Mg-salts against AZT (and other NRTIs)-mediated membrane and endothelial cell oxidative injury; (2) Assess if dietary supplementation of Mg-salts (Mg oxide and Mg- gluconate: 3 and 6- fold higher than normal) in the rat attenuates chronic AZT-induced cardiovascular inflammation, oxidative stress, and neutrophil activation; and (3) Determine if Mg-supplementation attenuates AZT-enhanced myocardial susceptibility to imposed ischemia/reperfusion (I/R) stress ex vivo. We will employ immunohistochemical and pathology techniques to localize inflammatory cyokines and white blood cell infiltrates. Oxidative stress in vivo will be determined biochemically by changes in tissue/blood glutathione status, iron status, and lipid peroxidation products (F2-isoprostanes, conjugated dienes). Changes in tolerance to perfused heart l/R-stress will be determined by free radical production (ESR spin trapping), and alterations in oxidative tissue injury markers and functional recovery. This proposed exploratory effort may reveal a potential usefulness of Mg-supplements as an effective, yet relatively inexpensive adjunct therapy to lessen NRTI-related cardiovascular toxicity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HAART-mediated Cardiovascular Toxcity in HIV-1 Transgenic Rats: Mg Protection
-
批准号:8906935
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2014
-
负责人:Ivan Tong Mak
-
依托单位:
HAART-mediated Cardiovascular Toxcity in HIV-1 Transgenic Rats: Mg Protection
-
批准号:8790053
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2014
-
负责人:Ivan Tong Mak
-
依托单位:
Cardioprotective Efficacy ofMg-Supplementation during HAART Therapy
-
批准号:8147831
-
项目类别:
-
资助金额:$19.37万
-
财政年份:2010
-
负责人:Ivan Tong Mak
-
依托单位:
Cardioprotective Efficacy ofMg-Supplementation during HAART Therapy
-
批准号:8070168
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2010
-
负责人:Ivan Tong Mak
-
依托单位:
Protective Efficacy of Mg-Supplementation Against NRTI-induced Cardiac Toxicity
-
批准号:7296101
-
项目类别:
-
资助金额:$18.57万
-
财政年份:2006
-
负责人:Ivan Tong Mak
-
依托单位:
国内基金
海外基金
登录
查看更多内容
慢性炎症诱发骨丢失的机制及外泌体靶向治疗策略研究
-
批准号:82370889
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅德皓
-
依托单位:
牙周炎对腹主动脉瘤的作用和机制研究
-
批准号:82370953
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:朱亚琴
-
依托单位:
衰老引起的大脑内稳态失调和神经炎症的机理与干预研究
-
批准号:92049303
-
项目类别:重大研究计划
-
资助金额:400.0万元
-
批准年份:2020
-
负责人:袁钧瑛
-
依托单位:
GSDMD介导的牙周膜干细胞焦亡在牙周炎致病机制中的作用
-
批准号:32000513
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:陈秦
-
依托单位:
脱硫弧菌通过肠肝轴诱导肝纤维化的机制研究
-
批准号:31970746
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2019
-
负责人:耿燕
-
依托单位:
炎性肠病中富亮氨酸重复激酶2对树突细胞迁移的作用及其机制
-
批准号:31801172
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2018
-
负责人:严静
-
依托单位:
幽门螺杆菌感染促进肿瘤相关成纤维细胞与胃癌细胞的互作及机制研究
-
批准号:31760328
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2017
-
负责人:周建奖
-
依托单位:
HDAC6调控巨噬细胞和中性粒细胞向炎症部位浸润的分子机理研究
-
批准号:31701216
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2017
-
负责人:谢松波
-
依托单位:
TRPV2在原发性肝癌中癌变作用的研究
-
批准号:81171933
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:徐迅迪
-
依托单位:
骨化三醇降低IgA肾病患者尿蛋白的机制研究
-
批准号:81100503
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:刘立军
-
依托单位: